Welcome to LookChem.com Sign In|Join Free
  • or
C31H27N3O4, also known as thalidomide, is a complex pharmaceutical compound composed of 31 carbon atoms, 27 hydrogen atoms, 3 nitrogen atoms, and 4 oxygen atoms. Thalidomide has a diverse range of effects on biological systems, which contributes to both its therapeutic potential and its harmful side effects.

1004551-40-9

Post Buying Request

1004551-40-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1004551-40-9 Usage

Uses

Used in Pharmaceutical Industry:
C31H27N3O4 is used as a sedative and antiemetic drug for its calming and nausea-reducing properties.
Used in Oncology:
C31H27N3O4 is used as an anticancer agent for its potential in treating certain types of cancer, despite its strict regulations and monitoring due to its teratogenic effects.
Used in Autoimmune Disease Treatment:
C31H27N3O4 is used as a therapeutic agent for autoimmune diseases, leveraging its interaction with biological systems to modulate immune responses.
Despite its infamous teratogenic effects when taken during pregnancy, leading to severe birth defects, thalidomide's complex chemical structure allows for its use in specific medical settings under stringent regulations and monitoring.

Check Digit Verification of cas no

The CAS Registry Mumber 1004551-40-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,5,5 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1004551-40:
(9*1)+(8*0)+(7*0)+(6*4)+(5*5)+(4*5)+(3*1)+(2*4)+(1*0)=89
89 % 10 = 9
So 1004551-40-9 is a valid CAS Registry Number.

1004551-40-9Downstream Products

1004551-40-9Relevant academic research and scientific papers

Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor

Priestley, E. Scott,De Lucca, Indawati,Zhou, Jinglan,Zhou, Jiacheng,Saiah, Eddine,Stanton, Robert,Robinson, Leslie,Luettgen, Joseph M.,Wei, Anzhi,Wen, Xiao,Knabb, Robert M.,Wong, Pancras C.,Wexler, Ruth R.

, p. 2432 - 2435 (2013/05/09)

A 6-amidinotetrahydroquinoline screening hit was driven to a structurally novel, potent, and selective FVIIa inhibitor through a combination of library synthesis and rational design. An efficient gram-scale synthesis of the active enantiomer BMS-593214 was developed, which required significant optimization of the key Povarov annulation. Importantly, BMS-593214 showed antithrombotic efficacy in a rabbit arterial thrombosis model. A crystal structure of BMS-593214 bound to FVIIa highlights key contacts with Asp 189, Lys 192, and the S2 pocket.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1004551-40-9